Dual Mechanism of Rag Gene Repression by c-Myb during Pre-B Cell Proliferation

REFERENCES

• Schlissel MS. 2003. Regulating antigen-receptor gene assembly. Nat Rev Immunol 3:890–899. https://doi.org/10.1038/nri1225.
   PubMedGoogle Scholar
• Schatz DG, Swanson PC. 2011. V(D)J recombination: mechanisms of initiation. Annu Rev Genet 45:167–202. https://doi.org/10.1146/annurev-genet-110410-132552.
   PubMed Web of Science ®Google Scholar
• Kuppers R, Dalla-Favera R. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20:5580–5594. https://doi.org/10.1038/sj.onc.1204640.
   PubMed Web of Science ®Google Scholar
• Lin WC, Desiderio S. 1994. Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc Natl Acad Sci U S A 91:2733–2737. https://doi.org/10.1073/pnas.91.7.2733.
   PubMed Web of Science ®Google Scholar
• Grawunder U, Leu TM, Schatz DG, Werner A, Rolink AG, Melchers F, Winkler TH. 1995. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3:601–608. https://doi.org/10.1016/1074-7613(95)90131-0.
   PubMedGoogle Scholar
• Li Z, Dordai DI, Lee J, Desiderio S. 1996. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity. 5:575–589. https://doi.org/10.1016/S1074-7613(00)80272-1.
   PubMed Web of Science ®Google Scholar
• Ochiai K, Maienschein-Cline M, Mandal M, Triggs JR, Bertolino E, Sciammas R, Dinner AR, Clark MR, Singh H. 2012. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol 13:300–307. https://doi.org/10.1038/ni.2210.
   PubMed Web of Science ®Google Scholar
• Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH, DePinho RA, Rickert RC. 2008. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 9:1388–1398. https://doi.org/10.1038/ni.1667.
   PubMed Web of Science ®Google Scholar
• Amin RH, Schlissel MS. 2008. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9:613–622. https://doi.org/10.1038/ni.1612.
   PubMed Web of Science ®Google Scholar
• Schulz D, Vassen L, Chow KT, McWhirter SM, Amin RH, Moroy T, Schlissel MS. 2012. Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1. J Exp Med 209:187–199. https://doi.org/10.1084/jem.20110645.
   PubMedGoogle Scholar
• Timblin GA, Schlissel MS. 2013. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development. J Immunol 191:4676–4687. https://doi.org/10.4049/jimmunol.1301675.
   PubMedGoogle Scholar
• Hsu LY, Lauring J, Liang HE, Greenbaum S, Cado D, Zhuang Y, Schlissel MS. 2003. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19:105–117. https://doi.org/10.1016/S1074-7613(03)00181-X.
   PubMed Web of Science ®Google Scholar
• Johnson K, Chaumeil J, Micsinai M, Wang JM, Ramsey LB, Baracho GV, Rickert RC, Strino F, Kluger Y, Farrar MA, Skok JA. 2012. IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycle. J Immunol 188:6084–6092. https://doi.org/10.4049/jimmunol.1200368.
   PubMedGoogle Scholar
• Muljo SA, Schlissel MS. 2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat Immunol 4:31–37. https://doi.org/10.1038/ni870.
   PubMed Web of Science ®Google Scholar
• Sandberg ML, Sutton SE, Pletcher MT, Wiltshire T, Tarantino LM, Hogenesch JB, Cooke MP. 2005. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 8:153–166. https://doi.org/10.1016/j.devcel.2004.12.015.
   PubMed Web of Science ®Google Scholar
• Zhao L, Glazov EA, Pattabiraman DR, Al-Owaidi F, Zhang P, Brown MA, Leo PJ, Gonda TJ. 2011. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb. Nucleic Acids Res 39:4664–4679. https://doi.org/10.1093/nar/gkr024.
   PubMedGoogle Scholar
• Kuwata N, Igarashi H, Ohmura T, Aizawa S, Sakaguchi N. 1999. Cutting edge: absence of expression of RAG1 in peritoneal B-1 cells detected by knocking into RAG1 locus with green fluorescent protein gene. J Immunol 163:6355–6359.
   PubMedGoogle Scholar
• Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J, Ideker T, Glass CK, Murre C. 2010. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11:635–643. https://doi.org/10.1038/ni.1891.
   PubMed Web of Science ®Google Scholar
• Gyory I, Boller S, Nechanitzky R, Mandel E, Pott S, Liu E, Grosschedl R. 2012. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev 26:668–682. https://doi.org/10.1101/gad.187328.112.
   PubMed Web of Science ®Google Scholar
• Chow KT, Timblin GA, McWhirter SM, Schlissel MS. 2013. MK5 activates Rag transcription via Foxo1 in developing B cells. J Exp Med 210:1621–1634. https://doi.org/10.1084/jem.20130498.
   PubMedGoogle Scholar
• Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS. 2013. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154:442–451. https://doi.org/10.1016/j.cell.2013.06.044.
   PubMed Web of Science ®Google Scholar
• Lupo A, Cesaro E, Montano G, Zurlo D, Izzo P, Costanzo P. 2013. KRAB-zinc finger proteins: a repressor family displaying multiple biological functions. Curr Genomics 14:268–278. https://doi.org/10.2174/13892029113149990002.
   PubMed Web of Science ®Google Scholar
• Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. 2005. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23:275–286. https://doi.org/10.1016/j.immuni.2005.08.005.
   PubMed Web of Science ®Google Scholar
• Fahl SP, Crittenden RB, Allman D, Bender TP. 2009. c-Myb is required for pro-B cell differentiation. J Immunol 183:5582–5592. https://doi.org/10.4049/jimmunol.0901187.
   PubMedGoogle Scholar
• Greig KT, de Graaf CA, Murphy JM, Carpinelli MR, Pang SH, Frampton J, Kile BT, Hilton DJ, Nutt SL. 2010. Critical roles for c-Myb in lymphoid priming and early B-cell development. Blood 115:2796–2805. https://doi.org/10.1182/blood-2009-08-239210.
   PubMedGoogle Scholar
• Parker D, Rivera M, Zor T, Henrion-Caude A, Radhakrishnan I, Kumar A, Shapiro LH, Wright PE, Montminy M, Brindle PK. 1999. Role of secondary structure in discrimination between constitutive and inducible activators. Mol Cell Biol 19:5601–5607. https://doi.org/10.1128/MCB.19.8.5601.
   PubMed Web of Science ®Google Scholar
• Nomura T, Tanikawa J, Akimaru H, Kanei-Ishii C, Ichikawa-Iwata E, Khan MM, Ito H, Ishii S. 2004. Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski. J Biol Chem 279:16715–16726. https://doi.org/10.1074/jbc.M313069200.
   PubMedGoogle Scholar
• Zhao H, Jin S, Gewirtz AM. 2012. The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemia. J Biol Chem 287:925–934. https://doi.org/10.1074/jbc.M111.279950.
   PubMedGoogle Scholar
• Bengtsen M, Klepper K, Gundersen S, Cuervo I, Drablos F, Hovig E, Sandve GK, Gabrielsen OS, Eskeland R. 2015. c-Myb binding sites in haematopoietic chromatin landscapes. PLoS One 10:e0133280. https://doi.org/10.1371/journal.pone.0133280.
   Google Scholar
• Shikatani EA, Chandy M, Besla R, Li CC, Momen A, El-Mounayri O, Robbins CS, Husain M. 2016. c-Myb regulates proliferation and differentiation of adventitial Sca1+ vascular smooth muscle cell progenitors by transactivation of myocardin. Arterioscler Thromb Vasc Biol 36:1367–1376. https://doi.org/10.1161/ATVBAHA.115.307116.
   PubMedGoogle Scholar
• Lei W, Liu F, Ness SA. 2005. Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1. Blood 105:3855–3861. https://doi.org/10.1182/blood-2004-08-3342.
   PubMedGoogle Scholar
• Quintana AM, Zhou YE, Pena JJ, O'Rourke JP, Ness SA. 2011. Dramatic repositioning of c-Myb to different promoters during the cell cycle observed by combining cell sorting with chromatin immunoprecipitation. PLoS One 6:e17362. https://doi.org/10.1371/journal.pone.0017362.
   Google Scholar
• Yu W, Misulovin Z, Suh H, Hardy RR, Jankovic M, Yannoutsos N, Nussenzweig MC. 1999. Coordinate regulation of RAG1 and RAG2 by cell type-specific DNA elements 5′ of RAG2. Science 285:1080–1084. https://doi.org/10.1126/science.285.5430.1080.
   PubMedGoogle Scholar
• Monroe RJ, Chen F, Ferrini R, Davidson L, Alt FW. 1999. RAG2 is regulated differentially in B and T cells by elements 5′ of the promoter. Proc Natl Acad Sci U S A 96:12713–12718. https://doi.org/10.1073/pnas.96.22.12713.
   PubMedGoogle Scholar
• Buckley RH. 2004. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22:625–655. https://doi.org/10.1146/annurev.immunol.22.012703.104614.
   PubMed Web of Science ®Google Scholar
• Kasper LH, Fukuyama T, Lerach S, Chang Y, Xu W, Wu S, Boyd KL, Brindle PK. 2013. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression. PLoS One 8:e82684. https://doi.org/10.1371/journal.pone.0082684.
   Google Scholar
• Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B. 2008. Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood 111:4771–4779. https://doi.org/10.1182/blood-2007-08-105072.
   PubMed Web of Science ®Google Scholar
• Sarvaiya PJ, Schwartz JR, Hernandez CP, Rodriguez PC, Vedeckis WV. 2012. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis. Am J Hematol 87:969–976. https://doi.org/10.1002/ajh.23283.
   PubMed Web of Science ®Google Scholar
• Waldron T, De Dominici M, Soliera AR, Audia A, Iacobucci I, Lonetti A, Martinelli G, Zhang Y, Martinez R, Hyslop T, Bender TP, Calabretta B. 2012. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia. 26:644–653. https://doi.org/10.1038/leu.2011.264.
   PubMedGoogle Scholar
• Pattabiraman DR, McGirr C, Shakhbazov K, Barbier V, Krishnan K, Mukhopadhyay P, Hawthorne P, Trezise A, Ding J, Grimmond SM, Papathanasiou P, Alexander WS, Perkins AC, Levesque JP, Winkler IG, Gonda TJ. 2014. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes. Blood 123:2682–2690. https://doi.org/10.1182/blood-2012-02-413187.
   PubMed Web of Science ®Google Scholar
• Uttarkar S, Dukare S, Bopp B, Goblirsch M, Jose J, Klempnauer KH. 2015. Naphthol AS-E phosphate inhibits the activity of the transcription factor Myb by blocking the interaction with the KIX domain of the coactivator p300. Mol Cancer Ther 14:1276–1285. https://doi.org/10.1158/1535-7163.MCT-14-0662.
   PubMedGoogle Scholar
• Uttarkar S, Dasse E, Coulibaly A, Steinmann S, Jakobs A, Schomburg C, Trentmann A, Jose J, Schlenke P, Berdel WE, Schmidt TJ, Muller-Tidow C, Frampton J, Klempnauer KH. 2016. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction. Blood 127:1173–1182. https://doi.org/10.1182/blood-2015-09-668632.
   PubMed Web of Science ®Google Scholar
• Lee IT, Johnstone SE, Young RA. 2006. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 1:729–748. https://doi.org/10.1038/nprot.2006.98.
   PubMed Web of Science ®Google Scholar